Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

1.0K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.0K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of an oral care bundle on salivary pH, dry mouth and ventilator-associated pneumonia in intubated patients: a randomized controlled trial.

BMC oral health·2026
Same author

The effect of industry-related air pollution on pulmonary function: A prospective, cross-sectional comparative study of industrial proximity and smoking status.

The Journal of international medical research·2026
Same author

IL-17, IL-23, and IL-36α Expression in Palmoplantar Psoriasis, Palmoplantar Eczema, and Plaque Psoriasis: Implications on Diagnosis and Treatment Selection.

Journal of cutaneous pathology·2026
Same author

ESPEN practical guideline on ethical aspects of medical nutrition therapy.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Susceptibility of carbapenem-resistant Klebsiella pneumoniae in urinary tract infections: clinical efficacy of fosfomycin.

Journal of infection in developing countries·2026
Same author

Post-intensive care unit (ICU) nutrition and rehabilitation: A multidisciplinary survey of healthcare professionals involved in ICU care.

Clinical nutrition ESPEN·2026

Related Experiment Video

Updated: Mar 19, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.7K

Neuromuscular Dysfunction in Experimental Sepsis and Glutamine.

İlkin Çankayalı1, Özden Boyacılar1, Kubilay Demirağ1

  • 1Department of Anesthesiology and Intensive Care, Ege University School of Medicine, İzmir, Turkey.

Balkan Medical Journal
|June 17, 2016
PubMed
Summary

Enteral glutamine supplementation prevented neuromuscular dysfunction in early sepsis. This study found that glutamine prevented prolonged muscle action potential latency in rats, suggesting its potential for sepsis-related nerve damage prevention.

Keywords:
Experimentalglutamineneuromuscularsepsis

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.9K
Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

18.8K

Related Experiment Videos

Last Updated: Mar 19, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.7K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.9K
Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

18.8K

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Biochemistry

Background:

  • Critical illness polyneuromyopathy develops early in sepsis, preceding clinical symptoms.
  • Sepsis-induced metabolic changes render glutamine a conditionally essential amino acid.

Purpose of the Study:

  • To evaluate the impact of glutamine supplementation on neuromuscular transmission during the early stages of sepsis.
  • To investigate the potential of glutamine in mitigating sepsis-associated neuromuscular dysfunction.

Main Methods:

  • Animal model study using male Sprague-Dawley rats.
  • Randomized controlled trial with a glutamine-supplemented group and a control group.
  • Assessment of compound muscle action potential (CMAP) latency before and 24 hours after cecal ligation and perforation (CLP) surgery.

Main Results:

  • Sepsis induction (CLP) led to prolonged CMAP latency in the control group (0.68±0.05 ms to 0.80±0.09 ms).
  • Glutamine supplementation significantly attenuated this prolongation, with latency changing from 0.69±0.07 ms to 0.73±0.07 ms (p<0.05).
  • Enteral glutamine effectively prevented the increase in CMAP latency observed in the early phase of sepsis.

Conclusions:

  • Enteral glutamine administration may prevent neuromuscular dysfunction in the early stages of sepsis.
  • Glutamine supplementation shows promise in mitigating sepsis-induced neuromuscular complications.
  • Further research is warranted to confirm these findings and explore clinical applications.